Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Growing Through Consolidation
D
Derek Hennecke
Partner
Inceptor Bio
Apr 6, 2017
PTV-M11-16-AP-008
CDMO
M&A
PA TV (video)
Derek Hennecke, Xcelience - a division of Capsugel, CEO and President
Related Content
Child Formulation
The Pediatric Formulation Gap
Pharma's Almanac
PAO-09-26-PA-05
Sep 7, 2026
Pathfinder
Conventional Peptide Synthesis vs. Recombinant Peptide Production: Which Manufacturing Strategy Is Better?
Nice Insight
PAO-26-PF-23
Sep 4, 2026
Productivity
The Next Productivity Leap in Mammalian Cell Culture
Pharma's Almanac
PAO-09-26-PA-03
Sep 3, 2026
Development CDMO
The Case for Earlier CDMO Involvement in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-02
Sep 2, 2026
M&A
Samsung Biologics Publishes Prospectus for PolyPeptide Public Tender Offer
Samsung Biologics
PR-09-26-01
Sep 1, 2026
Funding
Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion
Samsung Biologics
PR-08-26-03
Sep 1, 2026
Capacity
Is the Bioreactor Arms Race Over?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-01
Sep 1, 2026
Biologics
Commercial Thinking Begins in Clinical Phases
Mathias Kahl
IDT Biologika
PAO-08-26-CL-02
Sep 1, 2026
TPDs
Low Dose, High Impact: Microdosing, Content Uniformity, and Precision Control in TPDs
David O’Connell
PCI Pharma Services
PAO-08-26-CL-04
Aug 31, 2026
Lipase Risk
An Integrated Analytical Approach to Lipase Risk Management in Biologics Development
Kyeyeon Hur, Ph.D.; Jimin Kim, Ph.D.; Minjeong Lee; Soojeong Oh; Woojung Jun
Samsung Biologics
PAO-08-26-CL-10
Aug 31, 2026
New Brand
QPharma Builds on a Trusted Legacy to Shape the Future of Complex Drug Delivery
QPharma
PR-08-26-04
Aug 31, 2026
Partner Selection
How are organizations balancing cost with regulatory, supply chain, and reputational risk when selecting partners or sites?
Pharma's Almanac
PAO-08-26-RT-01
Aug 28, 2026
Previous slide
Next slide
